As for miR-576, our study was the first to reveal its potential as a biomarker for liver metastasis and the regulation mechanism involving downstream PTEN-P53/TGF-β signaling axis in the process of CRC cells undergoing liver metastasis. The gene discussed is TGFB1; the disease is colorectal carcinoma.